chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: 76yo male patient died on 7/6/2022 of unknown cause. Pt was last known to have transfered to community nursing facility on 6/14/2022 per medical chart note on 6/14/22 to medical facility. Pt with the following problem list: PROBLEM LAST PROVIDER Seen by palliative care medicine service (03/10/2022) (ICD-10-CM Z51.5) Critical illness myopathy 02/25/2022 (ICD-10-CM G72.81) Hyperlipidemia (ICD-10-CM E78.5) 12/15/2016 Cardiomyopathy (ICD-10-CM I42.9) 12/07/2016 Chronic atrial fibrillation 08/10/2016 (ICD-10-CM I48.1) Diabetic neuropathy (ICD-10-CM 06/02/2016 E11.40) Type 2 diabetes mellitus 11/30/2015 (ICD-10-CM E11.65) Male hypogonadism (ICD-10-CM 11/30/2015 E29.1) Chronic post-traumatic stress disorder (11/03/2015) (ICD-10-CM F43.12) Degeneration of lumbar intervertebral disc (11/02/2015) (ICD-10-CM M51.36) Iron deficiency anemia (ICD-10-CM 03/28/2018 D50.9) Congestive heart failure 12/19/2015 (ICD-10-CM I50.42) Spinal stenosis of lumbar region 06/13/2019 (ICD-10-CM M48.062) Osteoarthrosis, unspecified whether generalized 11/27/2017 or localized, involving lower leg (ICD-10-CM M17.9) Major Depressive Disorder, Recurrent Episode, 05/03/2016 Moderate Degree (ICD-10-CM F33.1) Coronary Atherosclerosis (unspecified type 01/14/2016 vessel, native or graft) (ICD-10-CM I44.0) (ICD-10-CM E66.9); Obesity 11/30/2015 (ICD-10-CM I25.10); Coronary artery disease 12/19/2015 (ICD-10-CM N18.3); Chronic kidney disease 12/15/2016 (ICD-9-CM V45.81); Postsurgical Aortocoronary 10/19/2011 Bypass Status (ICD-9-CM V45.81) (ICD-10-CM G47.30); Sleep apnea 12/15/2016) Essential Hypertension (ICD-10-CM 11/30/2015 I10) Gout (ICD-10-CM M10.9), Onset 02/15/2019 00/00/1992 Diverticulosis, colon (ICD-9-CM 562.10), Onset 02/16/1996 00/00/1992 Acute myocardial infarction, of other inferior 02/16/1996 wall, initial episode of care (ICD-9-CM 410.41), Onset 00/00/1992 Pt had received a covid vaccine on 5/26/2021 (Covid Vaccine EUA J&J). Death appears unrelated to patient's death given pt's age, medical problem list & long length of time between death & date covid vaccine was given.
On 19FEB92 pt seen by MD w/2.5 cm are above inject site, 8cm below & 6cm across arm;
Ringing in ears.  Not constant.  Some days far worse than others.  I had occasional ringing (1x per year) prior to shot, not it is constant.  It has no abated since the shot.  I have since had my 2nd shot and booster.  No difference in ringing with the 2nd or booster shot.
Severe pain in my left shoulder and arm.  I received the vaccination at 5:30 pm. At 2:00 am I woke up with severe, throbbing, searing pain into my shoulder joint and surrounding muscles and numbness and tingling down my arm to fingers.  I  gave birth to two children with zero pain medication and can tolerate high levels of pain, but this shoulder pain brought me to tears.  It?s 48 hours after the vaccination and I?m still in severe pain, the use and range of motion of my shoulder is extremely limited.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received its 30-days Expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received its 30-days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 41-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2022 at 1:25 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 19-Feb-2022 at 1:25 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received its 30-days Expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received its 30-days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        No concomitant medication was reported by reporter. No treatment medication was reported by reporter.
This case was reported by a physician via call center representative and described the occurrence of tenderness in a 86-year-old male patient who received SHINGRIX for prophylaxis. On 16th October 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 16th October 2018, less than a day after receiving SHINGRIX, the patient experienced tenderness. On an unknown date, the outcome of the tenderness was recovered/resolved. It was unknown if the reporter considered the tenderness to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for himself. At 14:00 hours, the patient received SHINGRIX in the deltoid. This case has been linked with the case US2018190183, reported by the same reporter.
Information has been received from a physician concerning an 11 year old male who on 30-NOV-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot# 658965/1355U). Suspect vaccination administered on that same day included a dose of Menactra in the left leg. Other concomitant drug therapy included Zyrtec and Flonase. On 01-DEC-2007 the patient was diagnosed with cellulitis characterized by pain in his leg (limped the entire day), a rash on the knee and into the groin and swelling in the interior thigh of his right leg. The patient sought unspecified medical attention. Subsequently, the patient recovered. There was no product quality complaint. Follow-up information from the reporting physician and medical records indicated that an 11 year old male with seasonal allergic rhinitis since 02-OCT-2006, a history of closed fracture of distal forearm (not specified) 09-NOV-2006 and no other medical conditions or allergies who on 30-NOV-2007 at 15:30 was vaccinated SC with his second dose of varicella virus vaccine live (Oka/Merck) (lot# 658965/1355U) in the right leg. There was no illness at the time of vaccination. Concomitant vaccination administered on that day at 15:30 included a dose of Menactra in the left leg. Other concomitant drug therapy initiated on 16-OCT-2007 included Zyrtec 10 mg chewables 1 tablet PO once daily and Flonase 50 mcg 2 sprays each nostril BID. PM 26-OCT-2007 the patient was started on acetaminophen (+) codeine 120-12 mg/5 mL solution 10 mL PO every 3 to 4 times per day. On 01-DEC-2007, at 9:00 the patient experienced pain, tenderness, and redness of the right leg. The patient was given Tylenol by his (a nurse in a pediatric outpatient department) for some relief from pain and swelling. The patient sought medical attention through a pediatric office visit on 03-DEC-2007. Remarkable exam findings included an alert, non-ill appearance with large erythema of right leg at the anterior thigh with swelling. There was no induration, drainage or purulence, but 2 small pimples with itchiness were noted. Visible lymph observed at the right side. The distal neurovascular (NV) status was normal and the left thigh was also normal. The patient's right thigh pain was rated as moderate (5/10). There were no other relevant diagnostic tests and laboratory data. The assessment was cellulitis of the right leg status post vaccination. The patient was treated with warm compresses and Motrin for 3 to 4 days. Subsequently, the patient recovered. Additional information has been requested.
Presented to ED with SOB. Rapid resp rate. O2 saturation in 70s at group home. O2 in 90s on arrival.
Ringing in ears (Tinnitus) started a day or two after second dose of vaccine.  I waited hoping that the condition would clear up. It did not. I went to my workplace clinic, was referred to my general practitioner, was referred to an ENT specialist , who ordered a hearing test, which has not been conducted yet. The Tinnitus has not subsided.
12/22/2020  2:50pm Shortly after the vaccine was administered experienced SOB and wheezing. Albuterol MDI utilized and symptoms subsided. 3:30pm Mild Headache and back pain. Fatigue and lethargic. Pain scale 3-4 5:15pm Headache increased intensity. Fatigue and lethargic. Back pain still the same, took Motrin 600mg-OTC  Wheezing, used Albuterol-MDI 7:30pm Headache and back pain increased intensity 12/23/2020 4:54am Woke up with wheezing, headache and back pain. Pain scale 6 Albuterol-MDI utilized 7:42am Wheezing and SOB, Albuterol utilized and symptoms subsided 3:00pm Headache increased intensity throughout the day. Difficulty focusing and multitasking. Loosing train of thought. Fatigue and lethargic. Pain scale7. Motrin OTC 800mg taken with evening medications and went to sleep. 12/24/2020 7:23am Woke up with severe headache and anosmia.  12/25/2020 Headache and anosmia 12/26/2020 Headache and anosmia 12/27/2020 COVID test-Negative result  Headache and anosmia 12/28/2020 Headache and anosmia 12/29/2020 Headache and anosmia. Doctor's appointment. Headache treated with Tramadol 12/30/2020 Headache and anosmia. Pain scale 6 12/31/2020 Headache and anosmia  Pain scale 3-4 01/01/2020 Headache and anosmia  Pain scale 2-3 01/02/2020Headache and anosmia  Pain scale 0-2 01/03/2020 Headache and anosmia  Pain scale 0-1 01/04/2020 Anosmia   01/05/2020 Headache and anosmia  Pain scale 2-3 01/06/2020 Headache and anosmia  Pain scale 3-4
He went to the doctor and had a stomach virus. He has 2 episodes of vomiting which were a week apart. He has had constipation and a temperature that was higher than normal. It's usually 97.5 degrees, but it was 99 degrees which is slightly elevated. Last month he gain his appetite back. His GI is on a more predictable schedule now. April 18, 2022 is when he threw up several times. His symptoms lasted from April 14th to May 1st off and on. They were mild symptoms. He had loose bowels, appetite was down, fatigued, laying down a lot, sleeping a lot, complained off and on of his stomach hurting, constipation, and an elevated temp. A couple days he would be better, but then he would be bad off and on intermittently.
Low grade fever for more than a month , ranging from 99.2 to 101.6. Fatigue
Unfamiliar taste in mouth accompanied by excessive salivation; Unfamiliar taste in mouth accompanied by excessive salivation; Severe muscle weakness at injection site; Severe muscle soreness/pain; Fatigue/tiredness; Gastrointestinal upset; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021(at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and genetically high total cholesterol (good Cholesterol also high from diet) from an unknown date. The patient had known allergies to sulfa drugs, contrast used with CT scans, gluten allergy, lots of hair/body products (cosmetic allergy), scents and smoke allergy. Concomitant medications included erenumab aooe (AIMOVIG); from an unknown date for an unknown indication and unknown if ongoing. The patient previously took Paba and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, within approximately 5 minutes of shot, the patient experienced unfamiliar taste in mouth accompanied by excessive salivation, severe muscle weakness at injection site within approximately 4 hours followed by severe muscle soreness/pain that gradually recovered after the duration of 2.5 days, fatigue/tiredness for 2 days, gastrointestinal upset and diarrhea starting within approximately 5 hours of shot and lasted approximately 5 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe muscle weakness at injection site, severe muscle soreness/pain, gastrointestinal upset and diarrhea was recovered on an unknown date in May2021. The clinical outcome of the event fatigue/tiredness was recovered on 02May2021. The clinical outcome of the event unfamiliar taste in mouth accompanied by excessive salivation was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
breakthrough covid-19 infection; breakthrough covid-19 infection; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 04Dec2021 12:30 (Lot number: FE3590) at the age of 64 years as dose 3 (booster), single, intramuscular, administered in arm left, administration date 01Apr2021 13:00 (Lot number: EL3247) as dose 2, single and intramuscular, administered in arm left, administration date 11Mar2021 13:15 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. Relevant medical history included: "afib" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "Allergies: environmental and food allergies" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL SUCCINATE; ROSUVASTATIN; METFORMIN; ASPIRIN [ACETYLSALICYLIC ACID]. Prior to vaccination, the patient was not diagnosed with COVID-19. The following information was reported: IMMUNISATION (medically significant) with onset 04Dec2021 12:30, outcome "unknown", described as "booster"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 30Dec2021, outcome "recovered" and all described as "breakthrough covid-19 infection". The event "breakthrough covid-19 infection" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (30Dec2021) positive, notes: Nasal Swab. Therapeutic measures taken as a result of the event included doxycycline hyclate 100mg.
Heart palpitations noted after each vaccine. Prompted me to seek out medical care and undergo EKG. EKG was unremarkable, however as palpitations persisted I was advised to start Magnesium supplements which reduced palpitations.
Limp, leg pain and some swelling to left thigh (inject site) still ambulatory. No fever. Some improvement at 48 hrs.
Vaccinated with Varivax 06/28/02. Dx with chickenpox on 03/07/2003.
presented @ ER 7 days p/vax w/generalized rash over entire body, target shaped rash w/green centers, fever 101; erythemia multiform, most likely due to MMR;
A little sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (A little sore arm after first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A, 038A21A and 002F21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder and Psoriasis. Concomitant products included RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced MYALGIA (A little sore arm after first dose). On 08-Mar-2021, MYALGIA (A little sore arm after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Skyrizi injection took by patient in Feb2021 600mg, and in May 2021 300mg and it is scheduled in SEP 2021.  No treatment information was reported by reporter.   This case was linked to MOD-2021-307235, MOD-2021-307237 (Patient Link).
Made a big kind of boil, real red and got big and ran a lot of puss and stuff came out of it. Sent him to school nurse every day put compresses on it. still doing bad took him to doctor and got antibiotic and will go back to doctor again. Doctor said she had never seen anything like it. She may have to call and tell to yall.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old female patient who received SHINGRIX for prophylaxis. On 5th May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX 3 months ago. Since then she had intermittent pain right where she received the injection. Most of the time she was fine but then all of a sudden she could feel where the shot was given. This did not happen every day. It was usually not a bad pain but last night, on 17th August 2018, it was much more severe. The patient had denied permission to contact their physician.
Fever (over four days), headache, diarrhea, fatigue, muscle ache, and loss of appetite.
Close to 9 months after being given the GARDASIL vaccine. I had a ct scan done, which showed that my lymph nodes were enlarged. A little over a year later. I was diagnosed with Hodgkin's Lymphoma -HL-. I am now undergoing chemotherapy treatment for this illness. This vaccine needs to be researched properly. I am convinced there is an increased risk for Lymphoma in women who were vaccinated. How many people have to die or get seriously sick for this vaccine to be investigated? I known of several women who became sick with Lymphoma months following vaccination with GARDASIL. I do not believe this is a mere coincidence. Statistical data would prove a connection, I'm certain. No oncologist or other doctor has ever asked me whether I was vaccinated with GARDASIL.  6/15/09 Oncology records received DOS 12/23/08 to 5/5/09. FINAL DIAGNOSIS: Hodgkin's Disease Lymphocytic Depletion, Unspec Site. Presented with complaints of fever and swollen cervical lymph nodes. Fatigue, pain/discomfort right neck. Night sweats. Decreased appetite. Muscle weakness and soreness in joints. Numbness right hand. Peri-anal itching, diarrhea, rectal fissure pain. Undergoing six cycles of chemotherapy. Has chemotherapy related side effects.  ICD-9 Code: 201.70  6/19/09 PMH records received. PMH:  Appy, ankle fx, ovarian cyst, blocked duct, UTI.  6/24/09 Medical, vaccine records received. DOS 4/23/07 to 5/17/07. Medical records consist of laboratory studies only.
A telephone report was received from a pharmacist on 01/26/01, regarding adverse events possibly related to administration of Fluvirin. Approximately one month after receiving Fluvirin, an 86 year old female developed: muscle weakness in her legs, cerebral vasculitis (confirmed at lumbar puncture) psychotic behavior, and was confused and agitated. This patient has a history of: untreated Parkinson's disease, hypertension, non-malignant brain tumor, atrial fibrillation, and has had "2 breastectomies". She has recently been diagnosed with lumbar disc disease; the brain tumor has been further identified as an acoustic tumor. Attempts to gather additional data have been unsuccessful.
FEVER DAY 7 AFTER VACCINE, SEIZURE ON DAY 8 AFTER VACCINE.   ADMITTED INPATIENT DUE TO CONTINUED SEIZURES.  IMPROVED ON DAY 15 AFTER VACCINES.
Pt denies any symptoms at this time, father was educated on side effects/adverse reactions.  High dose FLUAD given IM rather than Flulaval.  Pt father will contact his PCP  if any symptoms occur.
dose was for another patient in room 305A , HE WAS IN 305B . OUR IMMUNIZER WAS TOLD BY NURSE TO GO ADMINISTER VACCINE, CONSET WAS FILLED BY NURSE, PATIENT ISNT COHERENT , IMMUNIZER CHECKED TEMPERATURE , ADMINISTER, SIGNED CONSENTS , MARKED ARM AND LOT NUMBER . AFTER HE LEFT, FACILITY CALLED MENTIONING THEY DISCOVERED THEIR MISTAKE .  FACILITY HAD A DR ON SITE MONITORING PATIENT, HE WAS DOING WELL
On Sunday, I just felt a little bit off. My mom, who was going to be visiting, is in her 90's, so I wanted to be checked for COVID-19. I went to a local clinic and was tested for COVID-19 and was positive. I wasn't feeling too badly. I was mostly tired, but with company coming over, I wanted to be safe. He prescribed me molnupiravir. I believe I took it for ten days. I was more tired for that week. I took a nap every day. I wore my mask constantly, which I believe contributed to the fact that I developed thrush. I'm still experiencing a lot of fatigue. I don't have to nap as much, but I'm just tired a lot.
Left arm hurt immediately after injection. Thought this would go away after a few days. By 11/13/13 my whole arm was hurting - muscle very. My rheumatologist ordered med dose pack of cortisone. This helped some but all of symptoms did not resolve. Arm continued to hurt and ache. Finally saw PCP on 12/31/13. She said I had tendonitis. Sent to Ortho Dr. given cortisone shot and sent to physical therapy.
5pm-7:30pm-heart rate 133-143 (sitting & laying) normal "70's"- drank "sleepy time tea" w/valerin in it to reduce 7:30pm after tea 130-135 heart rate 8pm - took benedryl (1) & herbal "sleeprelief" with melatonin & valerin root in it to reduce. 11pm - heart rate-99 - went to bed 8AM - woke up 62-heart rate-normal
unknown. Case tested positive in hospital 04/06/2022 and was deceased 01/07/2022.
Bell's palsy; Eye twitching; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 27Jan2021 13:00 (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunisation. Medical history included high blood pressure and acid reflux. Other than those, patient was "pretty healthy." Patient was not diagnosed with COVID prior vaccination. Concomitant medications included irbesartan, pantoprazole, meloxicam, and biotin. Patient reported that she had Bell's palsy when she was in college. When she was teaching years later, she noticed that every year when she got the flu shot, her eye would twitch for about 8 or more weeks after the shot. She finally connected the fact that it was happening every year after the shot so she saw a neurologist. She was told that an egg derivative was used in the flu shot, which was connected to Epstein bar disease, which was connected to Bell's palsy. She was told to stop getting the flu shot so she quit getting the flu shot and never had another occurrence until after getting the COVID Pfizer shot. On 29Jan2021, the patient experienced bell's palsy and eye twitching. The twitch appeared a few days after getting the shot, but seemed mild enough, but as of late it has become quite an annoyance. The only thing she can attribute it to was the COVID vaccine. She was a little leery of getting a booster if necessary. No treatment was received. Outcome of the events was not recovered. Patient was not tested for COVID post vaccination.  Information about lot/batch number has been requested.
Pt seen for tingling of tongue and fingers, loss of taste sensation for 2-4 months after 2nd and 3rd anthrax immunizations.